产前抗生素暴露与儿童哮喘:基于人群的队列研究
该研究利用加拿大曼尼托巴省1996至2012年间213 661对母子的处方、住院和医生账单记录开展基于人群的队列研究,发现36.8%的儿童产前暴露于抗生素、10.1%罹患哮喘;产前抗生素暴露与哮喘风险升高相关(aHR 1.23,95%CI 1.20-1.27),且呈剂量依赖,但孕期前后9个月的母体抗生素使用也呈类似关联。
要点
- 产前抗生素暴露与儿童哮喘风险升高相关,aHR 1.23(95%CI 1.20-1.27)。
- 风险随产前抗生素疗程数增加而升高,三疗程及以上aHR 1.51。
- 孕前9个月与产后9个月母体抗生素使用亦呈类似关联,提示关联可能非孕期特异或非直接因果。
核心结论
- 产前抗生素暴露与儿童哮喘风险呈剂量依赖性升高相关。
- 但孕前和产后母体抗生素使用也呈类似关联,提示该关联可能并非直接因果,或并非孕期特异。
研究设计与样本
- 基于人群的队列研究,利用加拿大曼尼托巴省1996至2012年出生的213 661对母子的处方、住院和医生账单记录。
- 采用Cox回归分析,校正母体哮喘、产后抗生素及其他潜在混杂因素。
- 敏感性分析评估孕前和产后母体抗生素使用。
主要发现
- 36.8%的儿童产前暴露于抗生素,10.1%罹患哮喘。
- 产前抗生素暴露与哮喘风险升高相关(aHR 1.23,95%CI 1.20-1.27)。
- 呈剂量反应:一疗程aHR 1.15(95%CI 1.11-1.18),两疗程aHR 1.26(95%CI 1.21-1.32),三疗程及以上aHR 1.51(95%CI 1.44-1.59)。
- 孕前9个月母体抗生素使用aHR 1.27(95%CI 1.24-1.31),产后9个月aHR 1.32(95%CI 1.28-1.36)。
临床怎么用
- 临床评估儿童哮喘风险时可关注产前抗生素暴露史及疗程数。
- 应结合母体孕期前后抗生素使用综合判断,不宜将产前暴露单独视为因果因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antibiotic use during infancy alters gut microbiota and immune development and is associated with an increased risk of childhood asthma. The impact of prenatal antibiotic exposure is unclear. We sought to characterise the association between prenatal antibiotic exposure and childhood asthma.We performed a population-based cohort study using prescription records, hospitalisation records and physician billing claims from 213 661 mother-child dyads born in Manitoba, Canada between 1996 and 2012. Associations were determined using Cox regression, adjusting for maternal asthma, postnatal antibiotics and other potential confounders. Sensitivity analyses evaluated maternal antibiotic use before and after pregnancy.36.8% of children were exposed prenatally to antibiotics and 10.1% developed asthma. Prenatal antibiotic exposure was associated with an increased risk of asthma (adjusted hazard ratio (aHR) 1.23, 95% CI 1.20-1.27). There was an apparent dose response (aHR 1.15, 95% CI 1.11-1.18 for one course; aHR 1.26, 95% CI 1.21-1.32 for two courses; and aHR 1.51, 95% CI 1.44-1.59 for three or more courses). Maternal antibiotic use during 9 months before pregnancy (aHR 1.27, 95% CI 1.24-1.31) and 9 months postpartum (aHR 1.32, 95% CI 1.28-1.36) were similarly associated with asthma.Prenatal antibiotic exposure was associated with a dose-dependent increase in asthma risk. However, similar associations were observed for maternal antibiotic use before and after pregnancy, suggesting the association is either not directly causal, or not specific to pregnancy.
引用
- Loewen K, Monchka B, Mahmud SM, et al. Prenatal antibiotic exposure and childhood asthma: a population-based study. Eur Respir J. 2018. PMID: 29678946. doi:10.1183/13993003.02070-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。